Published in Br J Clin Pharmacol on November 01, 1984
Comparison of ketanserin and slow-release nifedipine added to the treatment of hypertensive patients uncontrolled by a thiazide diuretic plus beta-adrenoceptor blocker. Br J Clin Pharmacol (1987) 0.87
Ketanserin in essential hypertension: use as monotherapy and in combination with a diuretic or beta-adrenoceptor antagonist. Br J Clin Pharmacol (1987) 0.83
Comparative trial of ketanserin or bendrofluazide as add-on therapy in hypertensive patients uncontrolled on a beta-blocker alone. Drugs (1988) 0.75
Receptor binding profile of R 41 468, a novel antagonist at 5-HT2 receptors. Life Sci (1981) 3.71
Vascular effects of ketanserin (R 41 468), a novel antagonist of 5-HT2 serotonergic receptors. J Pharmacol Exp Ther (1981) 3.47
Treatment of hypertension with ketanserin, a new selective 5-HT2 receptor antagonist. Br Med J (Clin Res Ed) (1982) 2.02
5-HT, alpha-adrenoceptors, and blood pressure. Effects of ketanserin in essential hypertension and autonomic insufficiency. Hypertension (1984) 1.58
Mechanism of the hypotensive effect of ketanserin. J Cardiovasc Pharmacol (1982) 1.48
Mechanism of antihypertensive action of ketanserin in man. Br Med J (Clin Res Ed) (1983) 1.47
Indirect blood pressure and heart rate measured quickly without observer bias using a semi-automatic machine (auto-manometer)--response to isometric exercise in normal healthy males and its modification by beta-adrenoceptor blockade. Br J Clin Pharmacol (1977) 1.39
Characterization of the antihypertensive properties of ketanserin (R 41 468) in rats. J Pharmacol Exp Ther (1982) 1.38
Ketanserin, a novel 5-hydroxytryptamine antagonist: monotherapy in essential hypertension. Br J Clin Pharmacol (1983) 1.35
5-HT2-receptor blockade in the treatment of heart failure. A preliminary study. Lancet (1981) 1.15
Cardiovascular effects in the rat of ketanserin, a novel 5-hydroxytryptamine receptor blocking agent. J Pharm Pharmacol (1982) 1.14
Ketanserin in hypertension. Early clinical evaluation and dose finding study of a new 5-HT2 receptor antagonist. Acta Med Scand (1983) 1.05
The antihypertensive effects of a pure and selective serotonin-receptor blocking agent (R 41 468) in elderly patients. Angiology (1981) 1.04
Ketanserin in essential hypertension: effects during rest and exercise. Eur J Clin Pharmacol (1983) 1.02
High-performance liquid chromatographic assay with fluorometric detection of ketanserin, a new antihypertensive agent and serotonin S2 antagonist in human plasma, blood and urine. J Chromatogr (1983) 0.90
Treatment of hypertension at an outpatient hypertension clinic. Blood pressure control, dropout rate, and side effects. Prev Med (1982) 0.79
Experience with ketanserin, a serotonin (S2) antagonist, in longterm treatment of essential hypertension. Clin Exp Hypertens A (1984) 0.79
Sequence determinants of cytosolic N-terminal protein processing. Eur J Biochem (1986) 5.59
Short-chain dehydrogenases/reductases (SDR). Biochemistry (1995) 5.34
Immunocytochemical detection and mapping of a cytokeratin 18 neo-epitope exposed during early apoptosis. J Pathol (1999) 3.28
Real-time biospecific interaction analysis using surface plasmon resonance and a sensor chip technology. Biotechniques (1991) 3.13
Medium- and short-chain dehydrogenase/reductase gene and protein families : the SDR superfamily: functional and structural diversity within a family of metabolic and regulatory enzymes. Cell Mol Life Sci (2008) 3.07
Feasibility of a nurse-monitored, outpatient-care programme for elderly patients with moderate-to-severe, chronic heart failure. Eur Heart J (1998) 2.49
Prospective randomized open blinded end-point (PROBE) study. A novel design for intervention trials. Prospective Randomized Open Blinded End-Point. Blood Press (1992) 2.49
Characteristics of alcohol/polyol dehydrogenases. The zinc-containing long-chain alcohol dehydrogenases. Eur J Biochem (1987) 2.17
Prediction of amyloid fibril-forming proteins. J Biol Chem (2000) 2.12
Low level exposure to cadmium and early kidney damage: the OSCAR study. Occup Environ Med (2000) 1.96
Structures of N-terminally acetylated proteins. Eur J Biochem (1985) 1.92
Morphine-3-glucuronide may functionally antagonize morphine-6-glucuronide induced antinociception and ventilatory depression in the rat. Pain (1992) 1.89
Felodipine--a new vasodilator, in addition to beta-receptor blockade in hypertension. Eur J Clin Pharmacol (1983) 1.77
SDR and MDR: completed genome sequences show these protein families to be large, of old origin, and of complex nature. FEBS Lett (1999) 1.73
Common structural features of MAPEG -- a widespread superfamily of membrane associated proteins with highly divergent functions in eicosanoid and glutathione metabolism. Protein Sci (1999) 1.70
Biospecific interaction analysis using surface plasmon resonance detection applied to kinetic, binding site and concentration analysis. J Chromatogr (1992) 1.67
Monoclonal antibodies against gastrointestinal tumour-associated antigens isolated as monosialogangliosides. Int Arch Allergy Appl Immunol (1983) 1.67
Exercise hemodynamics and myocardial metabolism during long-term beta-adrenergic blockade in severe heart failure. J Am Coll Cardiol (1991) 1.66
Survival in treated hypertension: follow up study after two decades. BMJ (1998) 1.64
[There is no reason to avoid calcium antagonists in hypertension]. Lakartidningen (1996) 1.62
Family infections by reo-like virus. Comparison of antibody titres by complement fixation and immunoelectroosmophoresis. Scand J Infect Dis (1977) 1.57
Health effects of working in pulp and paper mills: malignant diseases. Am J Ind Med (1996) 1.56
Cadmium exposure and end-stage renal disease. Am J Kidney Dis (2001) 1.55
Is high and fluctuating muscle nerve sympathetic activity in the sleep apnoea syndrome of pathogenetic importance for the development of hypertension? J Hypertens Suppl (1988) 1.55
Consensus predictions of membrane protein topology. FEBS Lett (2000) 1.55
Diabetes mellitus and raised serum triglyceride concentration in treated hypertension--are they of prognostic importance? Observational study. BMJ (1996) 1.54
Studies with ubiquinone-depleted submitochondrial particles. Essentiality of ubiquinone for the interaction of succinate dehydrogenase, NADH dehydrogenase, and cytochrome b. Eur J Biochem (1969) 1.53
Low-level cadmium exposure and osteoporosis. J Bone Miner Res (2000) 1.53
Relation between drug treatment and cancer in hypertensives in the Swedish Trial in Old Patients with Hypertension 2: a 5-year, prospective, randomised, controlled trial. Lancet (2001) 1.52
Dyspnoea, asthma, and bronchospasm in relation to treatment with angiotensin converting enzyme inhibitors. BMJ (1994) 1.52
Myocardial turnover of endogenous opioids and calcitonin-gene-related peptide in the human heart and the effects of spinal cord stimulation on pacing-induced angina pectoris. Cardiology (1998) 1.51
Radioimmunoassays for glutamic acid decarboxylase (GAD65) and GAD65 autoantibodies using 35S or 3H recombinant human ligands. J Immunol Methods (1995) 1.51
The effect of local anaesthetics on the central circulation and respiration in man and dog. Acta Anaesthesiol Scand (1968) 1.50
Haplotype association analysis of the polymorphisms Arg16Gly and Gln27Glu of the adrenergic beta2 receptor in a Swedish hypertensive population. J Hum Hypertens (2005) 1.45
Hunger behaviour contributes to early nutritional homeostasis. Acta Paediatr (1998) 1.42
The pattern of blood lipids, glycerol and ketone bodies during the neonatal period, infancy and childhood. Acta Paediatr Scand (1966) 1.42
Magnetic resonance imaging and aneurysm clips. Magnetic properties and image artifacts. J Neurosurg (1989) 1.41
Sensitivity and specificity of CA242 in gastro-intestinal cancer. A comparison with CEA, CA50 and CA 19-9. Br J Cancer (1992) 1.39
Psychotropic drug use in pregnancy and perinatal death. Acta Obstet Gynecol Scand (1992) 1.39
Blunted renal sodium excretion during acute saline loading in normotensive men with positive family histories of hypertension. Am J Hypertens (1991) 1.39
Ketanserin, a novel 5-hydroxytryptamine antagonist: monotherapy in essential hypertension. Br J Clin Pharmacol (1983) 1.35
Relationship between haemoglobin A1C in early type 1 (insulin-dependent) diabetic pregnancy and the occurrence of spontaneous abortion and fetal malformation in Sweden. Diabetologia (1990) 1.34
Isolation and characterization of porcine diazepam-binding inhibitor, a polypeptide not only of cerebral occurrence but also common in intestinal tissues and with effects on regulation of insulin release. Eur J Biochem (1988) 1.34
Studies with ubiquinone-depleted submitochondrial particles. Effects of extraction and reincorporation of ubiquinone on the kinetics of succinate dehydrogenase. Eur J Biochem (1970) 1.33
TMAP: a new email and WWW service for membrane-protein structural predictions. Trends Biochem Sci (1995) 1.32
Detection by monoclonal antibody of carbohydrate antigen CA 50 in serum of patients with carcinoma. Br Med J (Clin Res Ed) (1984) 1.31
Chronic lymphatic leukaemia and engine exhausts, fresh wood, and DDT: a case-referent study. Br J Ind Med (1988) 1.30
Cerebral blood flow and exchange of oxygen, glucose, ketone bodies, lactate, pyruvate and amino acids in infants. Acta Paediatr Scand (1976) 1.29
The Losartan Intervention For Endpoint reduction (LIFE) in Hypertension study: rationale, design, and methods. The LIFE Study Group. Am J Hypertens (1997) 1.28
Topical anesthesia with lidocaine aerosol in the control of postoperative pain. Anesthesiology (1988) 1.27
Biosynthesis of bile acids in man. Hydroxylation of the C27-steroid side chain. J Clin Invest (1975) 1.27
Brain natriuretic peptide predicts mortality in the elderly. Heart (1997) 1.27
Baroreflex modulation of sympathetic activity and sympathetic neurotransmitters in humans. Acta Physiol Scand (1988) 1.27
The cost-effectiveness of a cardiovascular multiple-risk-factor intervention programme in treated hypertensive men. J Intern Med (1995) 1.25
Increased glomerular filtration rate as a predictor of diabetic nephropathy--an 8-year prospective study. Kidney Int (1992) 1.24
Cysteine-scanning mutagenesis of putative helix VII in the lactose permease of Escherichia coli. Biochemistry (1994) 1.24
Catecholamine surge and metabolic adaptation in the newborn after vaginal delivery and caesarean section. Acta Paediatr Scand (1984) 1.23
Outcome of pregnancies complicated by type 1 insulin-dependent diabetes in Sweden: acute pregnancy complications, neonatal mortality and morbidity. Am J Perinatol (1993) 1.22
Effects of vagus nerve stimulation on amino acids and other metabolites in the CSF of patients with partial seizures. Epilepsy Res (1995) 1.22
Functional autoimmune epitope on alpha 1-adrenergic receptors in patients with malignant hypertension. Lancet (1994) 1.21
Active site directed mutagenesis of 3 beta/17 beta-hydroxysteroid dehydrogenase establishes differential effects on short-chain dehydrogenase/reductase reactions. Biochemistry (1997) 1.20
Adenosine mechanisms in the regulation of breathing in the rat. Eur J Pharmacol (1984) 1.20
Risk factors and clinical presentation of hepatobiliary carcinoma in patients with primary sclerosing cholangitis: a case-control study. Hepatology (1998) 1.19
Water intoxication associated with non-steroidal anti-inflammatory drug therapy. Acta Med Scand (1987) 1.18
Troglitazone, an insulin action enhancer, improves metabolic control in NIDDM patients. Troglitazone Study Group. Diabetologia (1996) 1.17
Cellular UDP-glucose deficiency caused by a single point mutation in the UDP-glucose pyrophosphorylase gene. J Biol Chem (1997) 1.17
Antinociceptive and ventilatory effects of the morphine metabolites: morphine-6-glucuronide and morphine-3-glucuronide. Eur J Pharmacol (1991) 1.16
Neonatal hypoglycemia: a discussion. J Pediatr (1971) 1.16
STOP-Hypertension 2: a prospective intervention trial of "newer" versus "older" treatment alternatives in old patients with hypertension. Swedish Trial in Old Patients with Hypertension. Blood Press (1993) 1.15
Blood cadmium as an indicator of dose in a long-term follow-up of workers previously exposed to cadmium. Scand J Work Environ Health (1997) 1.14
Atrial natriuretic peptides predict mortality in the elderly. J Intern Med (1997) 1.14
Protein structure prediction: recognition of primary, secondary, and tertiary structural features from amino acid sequence. Crit Rev Biochem Mol Biol (1995) 1.14
Short-term effects of felodipine, a new dihydropyridine, in hypertension. Br J Clin Pharmacol (1984) 1.14
Cardiovascular effects in the rat of ketanserin, a novel 5-hydroxytryptamine receptor blocking agent. J Pharm Pharmacol (1982) 1.14
Regional haemodynamic effects of endothelin-1 in rat and man: unexpected adverse reaction. J Hypertens (1990) 1.13
Binding and inhibition of myeloperoxidase (MPO): a major function of ceruloplasmin? Clin Exp Immunol (1997) 1.12
Role of glutamate-269 in the lactose permease of Escherichia coli. Mol Membr Biol (1994) 1.11
Only one DQ-beta restriction fragment pattern of each DR specificity is associated with insulin-dependent diabetes. J Immunol (1986) 1.11
Characterization of 4-hydroxyphenylpyruvate dioxygenase. Primary structure of the Pseudomonas enzyme. Eur J Biochem (1992) 1.11
Membrane-associated proteins in eicosanoid and glutathione metabolism (MAPEG). A widespread protein superfamily. Am J Respir Crit Care Med (2000) 1.11
Kinetic analysis of the interaction between protein A domain variants and human Fc using plasmon resonance detection. J Mol Recognit (1996) 1.10
Treatment of essential hypertension with felodipine in combination with a diuretic. Eur J Clin Pharmacol (1986) 1.10
Acetaminophen blocks spinal hyperalgesia induced by NMDA and substance P. Pain (1994) 1.09
Long term experience of felodipine in combination with beta-blockade and diuretics in refractory hypertension. Drugs (1985) 1.08
Adipose tissue fat cell size and number in relation to metabolism in endogenous hypertriglyceridemia. Acta Med Scand (1971) 1.08
The N-terminal domain of 5-lipoxygenase binds calcium and mediates calcium stimulation of enzyme activity. J Biol Chem (2000) 1.08
Fifty uremic patients treated with renal homotransplantation. Scand J Urol Nephrol (1968) 1.08
Antihypertensive effects of felodipine compared with placebo. Drugs (1985) 1.07
Multiple myeloma and engine exhausts, fresh wood, and creosote: a case-referent study. Am J Ind Med (1987) 1.07